SJS Investment Consulting’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31K | Sell |
4
-3
| -43% | -$979 | ﹤0.01% | 725 |
|
|
2025
Q1 | $1.89K | Buy |
7
+3
| +75% | +$810 | ﹤0.01% | 750 |
|
|
2024
Q4 | $942 | Sell |
4
-1
| -20% | -$236 | ﹤0.01% | 1017 |
|
|
2024
Q3 | $1.38K | Buy |
5
+1
| +25% | +$275 | ﹤0.01% | 953 |
|
|
2024
Q2 | $972 | Sell |
4
-1
| -20% | -$243 | ﹤0.01% | 1036 |
|
|
2024
Q1 | $748 | Buy |
5
+2
| +67% | +$299 | ﹤0.01% | 1146 |
|
|
2023
Q4 | $575 | Sell |
3
-4
| -57% | -$767 | ﹤0.01% | 1200 |
|
|
2023
Q3 | $1.24K | Buy |
7
+2
| +40% | +$354 | ﹤0.01% | 844 |
|
|
2023
Q2 | $950 | Buy |
5
+2
| +67% | +$380 | ﹤0.01% | 919 |
|
|
2023
Q1 | $601 | Hold |
3
| – | – | ﹤0.01% | 1089 |
|
|
2022
Q4 | $713 | Buy |
3
+2
| +200% | +$475 | ﹤0.01% | 1092 |
|
|
2022
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1014 |
|